Sundrug Co.,Ltd. (9989.T)
JPY 3932.0
(-0.13%)
JPY 3932.0
(-0.13%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 41.18 Billion | 37.38 Billion | 31.68 Billion | 31.76 Billion | 32.27 Billion | 31.09 Billion |
| Net Income | 29.12 Billion | 37.71 Billion | 34.67 Billion | 37.18 Billion | 34.64 Billion | 35.07 Billion |
| Depreciation & Amortization | 15.24 Billion | 12.06 Billion | 10.2 Billion | 8.66 Billion | 8.35 Billion | 8.24 Billion |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -2.05 Billion | -4.8 Billion | -1.26 Billion | -4.53 Billion | -1.03 Billion | -1.91 Billion |
| Other non-cash items | 39.55 Billion | -7.59 Billion | -11.93 Billion | -9.55 Billion | -9.69 Billion | -10.31 Billion |
| Investing Cash Flow | -74.85 Billion | -28.51 Billion | -20.65 Billion | -17.9 Billion | -13.95 Billion | -13.62 Billion |
| Investments in PPE | -38.22 Billion | -26.11 Billion | -19.78 Billion | -16.47 Billion | -11.3 Billion | -11.19 Billion |
| Acquisitions | - | -1 Billion | - | - | - | - |
| Investment purchases | -35.37 Billion | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -1.24 Billion | -1.39 Billion | -870 Million | -1.42 Billion | -2.64 Billion | -2.42 Billion |
| Financing Cash Flow | 22.48 Billion | -17.32 Billion | -8.18 Billion | -8.06 Billion | -7.86 Billion | -7.71 Billion |
| Debt repayment | -35 Billion | -7.27 Billion | - | - | - | - |
| Dividends payments | -12.51 Billion | -10.05 Billion | -8.18 Billion | -8.06 Billion | -7.86 Billion | -7.71 Billion |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -2 Million | -2 Million | - | - | - | - |
| Accounts receivables | -5.13 Billion | -2.67 Billion | -693 Million | -3.6 Billion | -5.13 Billion | -29 Million |
| Accounts payables | 3.36 Billion | 3.86 Billion | 1.73 Billion | 603 Million | 5.56 Billion | 33 Million |
| Inventory | -8.42 Billion | -7.19 Billion | -34 Million | -3.58 Billion | -1.48 Billion | -2.05 Billion |
| Other working capital | 8.13 Billion | 1.21 Billion | -2.27 Billion | 2.04 Billion | 14 Million | 143 Million |
| Cash at beginning of period | 80.87 Billion | 89.33 Billion | 86.49 Billion | 80.69 Billion | 70.23 Billion | 60.48 Billion |
| Cash at end of period | 69.69 Billion | 80.87 Billion | 89.33 Billion | 86.49 Billion | 80.69 Billion | 70.23 Billion |
| Capital Expenditure | -38.22 Billion | -26.11 Billion | -19.78 Billion | -16.47 Billion | -11.3 Billion | -11.19 Billion |
| Effect of forex changes on cash | - | - | -1 Million | - | -1 Million | - |
| Net cash flow / Change in cash | -11.17 Billion | -8.45 Billion | 2.83 Billion | 5.79 Billion | 10.46 Billion | 9.75 Billion |
| Free Cash Flow | 2.96 Billion | 11.26 Billion | 11.89 Billion | 15.28 Billion | 20.97 Billion | 19.89 Billion |
| Breakdown | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 7.29 Billion | 29.12 Billion | 6.34 Billion | 8.72 Billion | 7.15 Billion | 6.9 Billion |
| Depreciation & Amortization | - | 15.24 Billion | 4.06 Billion | 3.81 Billion | 3.68 Billion | 3.3 Billion |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | -2.05 Billion | -4.85 Billion | - | - | - |
| Other non-cash items | -7.29 Billion | 39.55 Billion | -6.34 Billion | -8.72 Billion | -7.15 Billion | -6.9 Billion |
| Investing Cash Flow | - | -74.85 Billion | -26.56 Billion | - | - | - |
| Investments in PPE | - | -38.22 Billion | -8.31 Billion | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | -35.37 Billion | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | -1.24 Billion | -18.25 Billion | - | - | - |
| Financing Cash Flow | - | 22.48 Billion | 14.12 Billion | - | - | - |
| Debt repayment | - | -35 Billion | - | - | - | - |
| Dividends payments | - | -12.51 Billion | -3.33 Billion | - | - | - |
| Common Stock Repurchased | - | - | -41.5 Million | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | -2 Million | 17.49 Billion | - | - | - |
| Accounts receivables | - | -5.13 Billion | -1.97 Billion | - | - | - |
| Accounts payables | - | 3.36 Billion | - | - | - | - |
| Inventory | - | -8.42 Billion | -2.48 Billion | - | - | - |
| Other working capital | - | 8.13 Billion | -402 Million | - | - | - |
| Cash at beginning of period | - | 80.87 Billion | - | 76.8 Billion | 68.81 Billion | 80.87 Billion |
| Cash at end of period | - | 69.69 Billion | -3.55 Billion | 67.25 Billion | 76.8 Billion | 68.81 Billion |
| Capital Expenditure | - | -38.22 Billion | -8.31 Billion | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | - | -11.17 Billion | -3.55 Billion | -9.55 Billion | 7.98 Billion | -12.05 Billion |
| Free Cash Flow | - | 2.96 Billion | 571 Million | 7.62 Billion | 7.37 Billion | 6.61 Billion |
8051
603557
CLVT
SNIM
4551
GANESHHOUC